Takeda's Try For Nycomed Would Boost Expansion Plan For Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical plans its entry into emerging markets to take place once it acquires Nycomed, a Switzerland based drug maker with a presence in more than 70 nations